ArticleOxidative medicine and cellular longevity2018

Corrigendum to "The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases".

Shuang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.